PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

GLP-2 Prevents Neuronal and Glial Changes in the Distal Colon of Mice Chronically Treated with Cisplatin.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33238628 ↗2020Reported benefit

GLP-2 Prevents Neuronal and Glial Changes in the Distal Colon of Mice Chronically Treated with Cisplatin.

MouseChemical/toxinC57BL/6Femalen = 24 mice; control n=3, vehicle n=3, GLP-2 n=6, cisplatin n=6…Intraperitoneal50 micrograms/kgCo-administered, started on the same day as the first cisplatin dose

Model: Chronic cisplatin-induced colonic mucosal and enteric nervous system injury, cisplatin 4 mg/kg intraperitoneally twice weekly for 4 weeks with subcutaneous saline to limit nephrotoxicity

[Gly2]GLP-2 co-administration prevented the cisplatin-induced loss of total myenteric neurons, nNOS-immunoreactive neurons and SOX-10-immunoreactive glia and normalised IL-1beta and IL-10. Protection was partial, since weight loss, reduced mucosal area and PAS staining, reduced GFAP and S100beta an…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.